07:00 , Aug 2, 2010 |  BC Week In Review  |  Clinical News

Vical preclinical data

In mice, Vical's prophylactic Vaxfectin-formulated plasmid DNA HSV-2 vaccine encoding the human herpes simplex type 2 (HSV-2) glycoprotein D antigen elicited antibody responses in 100% of mice, protected 100% of mice from a lethal HSV-2...